Golden
Global Life Sciences Ventures

Global Life Sciences Ventures

Global Life Sciences Ventures is a venture capital fund focused on life sciences.

Global Life Science Ventures is a venture capital firm focusing on the life science sector. The firm is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The firm was founded in 1996 and is based in Munich, Germany.

Global Life Science Ventures also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance, advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.

Investment

Global Life Sciences Ventures' investments include Binx Health, Santaris Pharma, Action Pharma, Coapt Systems, Agendia, Nitec Pharma, Pieris Pharmaceuticals, NeurogesX and Spinal Cord Therapeutics.

Their exited investments include Santaris Pharma, NeurogesX, Cytos, Zalicus, Coapt Systems, Coley Pharmaceutical Group, Roche Glycart, Intercell and Pieris Pharmaceuticals.

Timeline

People

Name
Role
LinkedIn

Dr. Hans A. Küpper

Partner

Dr. Ing. Peter H. Reinisch

Partner

Hanns-Peter Wiese

Partner

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References